✦ LIBER ✦

Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies

✍ Scribed by Guo, Ya-Jun; Che, Xiao-Yan; Shen, Feng; Xie, Tian-Pei; Ma, Jing; Wang, Xiao-Ning; Wu, Shu-Guang; Anthony, Donald D.; Wu, Meng-Chao

Book ID: 109928172
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 447 KB
Volume: 3
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm0497-451

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of in vitro tumor cell growth

Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies

✍ Gregory Lee; Bixia Ge 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 393 KB

Selective killing of tumor cells in vitr

Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen

✍ Wu Min; Tang Si-lun; Zang Ren-jie; Yu He 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Rapid detection of S-phase cells by anti

Rapid detection of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in 9L brain tumor cells in vitro and in situ

✍ T. Nagashima; T. Hoshino 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 562 KB

Bispecific F(ab′)2 monomer prepared with

Bispecific F(ab′)2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells

✍ Taizo Nitta; Hideo Yagita; Takachika Azuma; Kiyoshi Sato; Ko Okumura 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

## Bispecific F(ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells Induction of cytolytic activity of peripheral blood mononuclear cells towards target cells was studied by preparing bispecific F(ab')2 which was compo

Therapeutic effects of monoclonal antibo

Therapeutic effects of monoclonal antibody g250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts

✍ J. van Dijk; H. Uemura; A. J. M. C. Beniers; W. P. Peelen; S. Th. Zegveld; G. J. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 1015 KB

Because renal-cell carcinoma (RCC) is considered relatively resistant to radio-and chemotherapy, RCC patients may benefit from new treatment modalities, e.g. immunotherapy. In vitro and in vivo studies suggest that combinations of cytokines such as interferon y or interferon a (IFN-y, IFN-a) and tum

Enhanced antitumor effect against human

Enhanced antitumor effect against human telomerase reverse transcriptase (hTERT) by vaccination with chemotactic-hTERT gene-modified tumor cell and the combination with anti-4-1BB monoclonal antibodies

✍ Xiaoyan Lin; Chunxia Zhou; Shengdian Wang; Dongmei Wang; Wenbo Ma; Xiao Liang; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 645 KB

## Abstract Human telomerase reverse transcriptase (hTERT) represents an attractive target for cancer immunotherapy because hTERT is reactivated in most human tumors. In an attempt to develop an effective vaccine against most human cancers, we constructed chemotactic‐hTERT vaccine. Two hTERT fragme